Infosys completes acquisition Kaleidoscope Innovation
The collaboration aims to revolutionise patient care, treatment, diagnostics and consumer health, across the world
Infosys has completed the acquisition of Kaleidoscope Innovation, a full-spectrum product design, development and insights firm innovating across medical, consumer and industrial markets, bolstering capabilities in the design of smart products. This follows the announcement the company made on September 3, 2020.
The acquisition demonstrates Infosys’ commitment to innovate for its clients, and make a meaningful impact on human lives through a combination of cutting-edge technologies. This collaboration further aims to revolutionise patient care, treatment, diagnostics and consumer health, across the world.
With Kaleidoscope Innovation, Infosys will further strengthen its digital offerings and also its workforce, with a diverse talent pool with extensive knowledge of design and engineering. Kaleidoscope leverages a deep understanding of clinical environments, strong product development capabilities across domains, and a consultancy-style approach addressing human factors, product design, UI/UX design, research and insight, development and visualisation. It serves a marquee and diversified customer base with state of the art, in-house labs, 3D design environments and customer experience centres.
Kaleidoscope Innovation designs microsurgical instruments, devices used in minimally invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables. It also offers usability testing in support of regulatory submissions, including the delivery mechanism for aortic stents.
